Composition comprising physcion isolated from extract of rhei rhizoma for treating and preventing cognitive dysfunction
KR20080032494A
A composition comprising an extract of rhei rhizoma or physcion compound isolated therefrom for treating or preventing cognitive dysfunction
KR20080030869A
Composition comprising benzofuran type derivative for treating and preventing cognitive dysfunction
KR20080023942A
Diagnostic kit for alzheimer's disease comprising antibodies specific for human transthyretin
KR20070054915A
Composition comprising flavone type flavonoid for treating and preventing cognitive dysfunction
KR20050004006A
4-(methylsulfonylamino)phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical composition containing the same
WO2004074837A1
Method for measuring the level of anti-beta-amyloid antibody in body fluids and diagnostic kit for alzheimer’s disease using same
KR20040087208A
Method for production of human lactoferrin using methylotrophic yeast, Pichia pastoris, human lactoferrin manufactured thereby and Pichia pastoris
KR20040034804A
Novel N-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions containing the same
KR20030026853A
Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
KR20030073779A
RECOMBINANT β-AMYLOID AND PROCESS FOR THE MASS-PRODUCTION THEREOF
KR20030041458A
Transgenic animal with genes relating to Alzheimer's disease and the method of producing thereof
KR20020084311A
Composition for preventing or treating involutional brain diseases comprising a hydrolysate of ginsenosides
KR20020002188A
Process for production of beta-secretase
KR20020013109A
Zinc anc zinc chelator as control factor of ps1 protein with gamma-secretease activity
KR20010092486A
Method for measuring concentration of amikacin in serum
KR20010092485A
Method for measuring concentration of theophylline in serum
KR20010092483A
Method for measuring concentration of valproic acid in serum
KR20010092484A
Method for measuring concentration of ethosuximide in serum